So, how much cash should you have on hand? To cushion the blow in a market downturn, Orman recommends stashing away three to five years’ worth of living expenses in a liquid, low-risk account ...

Nasir Baskerville Officers were at St. Christopher's Hospital on Saturday when the child arrived by private vehicle, suffering from a laceration to the hand. According to police, an investigation ...

A major strategic achievement was the successful closure of the Cylance transaction with Arctic Wolf, which brought in approximately $80 million in cash and 5.5 million common shares. The company ...

GREEN BAY (WLUK) -- With many schools in the Green Bay area canceling classes during the NFL Draft, school food service will be disrupted -- leaving children in need without access to regular meals.

We recently published a list of 13 Best Canadian Penny Stocks to Invest in Now In this article, we are going to take a look at where BlackBerry Limited (NYSE:BB) stands against other best Canadian ...

But Dubas doesn’t plan to go down that route. "You can hope in one hand and s--- in the other and see which one fills up first," he said. He compared his team to the Washington Capitals ...

A woman chose to have her right hand amputated after a simple inch-long dog scratch left her battling the 'suicide disease'. Gill Haddington, 48, had her right leg amputated below the knee on May ...

Cam Jurgens, Jason Kelce's replacement at center for the Philadelphia Eagles, has reached an agreement over a huge new $68million contract. Jurgens was a vital part of Philly's Super Bowl-winning ...

A major strategic achievement was the successful closure of the Cylance transaction with Arctic Wolf, which brought in approximately $80 million in cash and 5.5 million common shares. The company ...

The company also reported a significant increase in its cash position, now totaling $410 million, partly due to improved operating cash flow and proceeds from the sale of Cylance. Despite these ...

Danish dermatology specialist LEO Pharma could be just weeks away from EU approval for delgocitinib, a treatment for chronic hand eczema (CHE) considered to be its top pipeline prospect.

Biogen has revealed encouraging phase 2 results with its anti-CD38 antibody felzartamab in rare kidney disease IgA nephropathy (IgAN), which it hopes could join a series of first-in-class ...